| Item 1. | |
| (a) | Name of issuer:
Vincerx Pharma, Inc. |
| (b) | Address of issuer's principal executive offices:
260 SHERIDAN AVENUE, SUITE 400, PALO ALTO, CALIFORNIA
94306 |
| Item 2. | |
| (a) | Name of person filing:
Sage Rhino Capital, LLC |
| (b) | Address or principal business office or, if none, residence:
101 Jefferson Drive
Menlo Park, CA
94025 |
| (c) | Citizenship:
Sage Rhino Capital, LLC - CALIFORNIA |
| (d) | Title of class of securities:
Common Stock |
| (e) | CUSIP No.:
92731L106 |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) |  Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
| (e) |  An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
|
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
|
| | |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
4,260 |
| (b) | Percent of class:
0 %
|
| (c) | Number of shares as to which the person has:
|
| | (i) Sole power to vote or to direct the vote:
Sage Rhino Capital, LLC - 4,260
|
| | (ii) Shared power to vote or to direct the vote:
Sage Rhino Capital, LLC - 0
|
| | (iii) Sole power to dispose or to direct the disposition of:
Sage Rhino Capital, LLC - 0
|
| | (iv) Shared power to dispose or to direct the disposition of:
Sage Rhino Capital, LLC - 0
|
| Item 5. | Ownership of 5 Percent or Less of a Class. |
| |
Ownership of 5 percent or less of a class
|
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
| |
Not Applicable
|
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| |
Not Applicable
|
| Item 8. | Identification and Classification of Members of the Group. |
| |
Not Applicable
|
| Item 9. | Notice of Dissolution of Group. |
| |
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.
VINCERX Pharma is pending dissolution. |